Exposing Pharmaceutical Accountability

This chapter investigates the accountability of pharmaceutical companies, focusing on a notable case of misconduct that led to legal repercussions. The speaker shares insights from a decade of litigation as an expert witness, illustrating how drug companies manipulate clinical trial data for profit. It underscores the implications of such practices on public health, medical literature integrity, and the need for reform in the industry.